Patient outcome prediction using multiple biomarkers in human melanoma: A clinicopathological study of 118 cases

Experimental and Therapeutic Medicine

Volumn 2, Issue 1, 2011, Pages 131-135

  Li, Jun ^a   Zhang, Zhizhong ^a   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Biomarker; Melanoma; Prognosis; Tissue microarray

Indexed keywords

BIM PROTEIN; BREAST CANCER METASTASIS SUPPRESSOR 1 PROTEIN; BRG1 PROTEIN; COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF GROWTH FAMILY MEMBER 4 PROTEIN; PROTEIN; PUMA PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SWI SNF RELATED MATRIX ASSOCIATED ACTIN DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY B MEMBER 1 PROTEIN; TRANSCRIPTION FACTOR SOX4; TUMOR MARKER; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL TIME; TUMOR VOLUME;

EID: 78751613512     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.169     Document Type: Article

References (27)

1. Howe HL, Wingo PA, Thun MJ, et al: Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93: 824-842, 2001.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer Statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
3. Jemal A, Thomas A, Murray T and Thun M: Cancer statistics, 2002. CA Cancer J Clin 52: 23-47, 2002.
4. Jafarnejad SM, Wani AA, Martinka M and Li G: Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am J Pathol: Oct. 15, 2010 (E-pub ahead of print).
5. Dai DL, Wang Y, Liu M, Martinka M and Li G: Bim expression is reduced in human cutaneous melanomas. J Invest Dermatol 128: 403-407, 2008.
6. Tang L, Dai DL, Su M, Martinka M, Li G and Zhou Y: Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res 12: 3716-3722, 2006.
7. Li J, Martinka M and Li G: Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis 29: 1373-1379, 2008.
8. Gao K, Dai DL, Martinka M and Li G: Prognostic significance of nuclear factor-κB p105/p50 in human melanoma and its role in cell migration. Cancer Res 66: 8382-8388, 2006.
9. Karst AM, Dai DL, Martinka M and Li G: PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene 24: 1111-1116, 2005.
10. Lin H, Wong RP, Martinka M and Li G: Loss of SNF5 expression correlates with poor patient survival in melanoma. Clin Cancer Res 15: 6404-6411, 2009.
11. Lin H, Wong RP, Martinka M and Li G: BRG1 expression is increased in human cutaneous melanoma. Br J Dermatol 163: 502-510, 2010.
12. Cheng Y, Li J, Martinka M and Li G: The expression of NAD(P)H: quinone oxidoreductase 1 is increased along with NF-κB p105/p50 in human cutaneous melanomas. Oncol Rep 23: 973-979, 2010
13. Li J, Cheng Y, Tai D, Martinka M, Welch DR and Li G: Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Oncogene: Oct. 11, 2010 (E-pub ahead of print).
14. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987.
15. Torabian S and Kashani-Sabet M: Biomarkers for melanoma. Curr Opin Oncol 17: 167-171, 2005.
16. Chen L, Willis SN, Wei A, et al: Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403, 2005.
17. Vaidya KS, Harihar S, Phadke PA, et al: Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. J Biol Chem 283: 28354-28360, 2008.
18. Hedley BD, Welch DR, Allan AL, et al: Down-regulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. Int J Cancer 123: 526-534, 2008.
19. Yang J, Zhang B, Lin Y, Yang Y, Liu X and Lu F: Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression. Cancer Lett 269: 46-56, 2008.
20. Shiseki M, Nagashima M, Pedeux RM, et al: p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 63: 2373-2378, 2003.
21. Garkavtsev I, Kozin SV, Chernova O, et al: The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428: 328-332, 2004.
22. Planchon SM, Pink JJ, Tagliarino C, Bornmann WG, Varnes ME and Boothman DA: β-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3. Exp Cell Res 267: 95-106, 2001.
23. Yu J and Zhang L: PUMA, a potent killer with or without p53. Oncogene 27 (Suppl 1): S71-S83, 2008.
24. Pan X, Zhao J, Zhang WN, et al: Induction of SOX4 by DNAdamage is critical for p53 stabilization and function. Proc Natl Acad Sci USA 106: 3788-3793, 2009.
25. Li X, Zhang Q, Cai L, et al: Inhibitor of growth 4 induces apoptosis in human lung adenocarcinoma cell line A549 via Bcl-2 family proteins and mitochondria apoptosis pathway. J Cancer Res Clin Oncol 135: 829-835, 2009.
26. Garate M, Wong RP, Campos EI, Wang Y and Li G: NAD(P)Hquinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep 9: 576-581, 2008.
27. Li J, Wang Y, Wong RP and Li G: The role of ING tumor suppressors in UV stress response and melanoma progression. Curr Drug Targets 10: 455-464, 2009.